The Utility of Sex-Specific Cut-offs for High-Sensitivity Troponin T for Long-Term All-cause Mortality Risk Assessment in Heart Failure
References
- WANG N., EVANS J., SAWANT S., SINDONE J., LAL S., WANG N. Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients. Heart Fail. Rev. 2022;
- MCDONAGH T.A., GARDNER R.S., BAUMBACH A., BO M., FRANCE M.G., HEYMANS S. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599–3726.
- HEIDENREICH P.A., BOZKURT B., AGUILAR D., ALLEN L.A., COLVIN M.M., DESWAL A., et al. 2022 AHA / ACC / HFSA Guideline for the Management of Heart Failure. Circulation. 2022;79(17).
- KENCHAIAH S., VASAN R.S. Heart Failure in Women - Insights from the Framingham Heart Study. Cardiovasc. Drugs Ther. 2015;29(4):377–390.
- AZAD N., KATHIRAVELU A., MINOOSEPEHER S., HEBERT P., FERGUSSON D. Gender differences in the etiology of heart failure : A systematic review. J. Geriatr. Cardiol. 2011;8(1):15–23.
- MARTÍNEZ-SELLÉS M., DOUGHTY R., POPPE K., WHALLEY G., EARLE N., TRIBOUILLOY C. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Hear. Fail. 2012;14(5):473–479.
- DANIELSON C., LILEIKYTE G., OUWERKERK W., LAM C., ERLINGE D., TENG T. Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta-analysis. ESC Hear. Fail. 2022;9(4):2753–2761.
- LAM C.S.P., ARNOTT C., BEALE A.L., CHANDRAMOULI C., HILFIKER-KLEINER D., KAYE D.M., et al. Sex differences in heart failure. Eur Hear. J. 2019;1–13.
- HALL P., NAH G., HOWARD B., LEWIS C., ALLISON M., SARTO G. Reproductive factors and incidence of heart failure hospitalization in the Women’s Health Initiative. J Am Coll Cardiol. 2017;69(20):2517–2526.
- VERGARO G., GENTILE F., AIMO A., JANUZZI JR J.L., RICHARDS A.M., LAM C.S.P., et al. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure. ESC Hear. Fail. 2022;9(4):2084–2095.
- LJUNG U., LUND L.H., ORSINI N., STRÖMBERG A., ANDERSSON D.C., LINDE C., et al. N-terminal pro-B-type natriuretic peptide in chronic heart failure : The impact of sex across the ejection fraction spectrum. Int. J. Cardiol. 2019;287:66–72.
- DELCURATOLO E., PALAZZUOLI A., COPPI F., MATTIOLI A.V., SEVERINO P., TRAMONTE F., et al. Risk Factors and Cellular Differences in Heart Failure : The Key Role of Sex Hormones. Biomedicines. 2023;11(11):1–18.
- LAU E.S., BINEK A., PARKER S.J., SHAH S.H., ZANNI M. V, EYK J.E. Van, et al. Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications. Circ. Res. 2023;130(4):578–592.
- DRAGHICI A., BUZEA C.A., DELCEA C., DAN G.A. Predictors associated with increased troponin in acute decompensated and chronic heart failure patients. Rev. Română Med. Lab. 2021;29(2):1–12.
- BISACCIA G., RICCI F., KHANJI M.Y., GAGGI G., CREDICO A. Di, GALLINA S., et al. Prognostic Value of High-Sensitivity Cardiac Troponin in Women. Biomolecules. 2022;12(10):1–12.
- MCEVOY J.W., TANG O., WANG D., NDUMELE C.E., CORESH J., CHRISTENSON R.H., et al. Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults. J. Am. Coll. Cardiol. 2023;81(20).
- THYGESEN K., ALPERT J.S., JAFFE A.S., CHAITMAN B.R., BAX J.J., MORROW D.A., et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138.
- AIMO A., JANUZZI J.J., VERGARO G., RIPOLI A., LATINI R., MASSON S. Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation. 2018;137(3):286–297.
- GOHAR A., CHONG J.P.C., LIEW O.W., RUIJTER H. Den, KLEIJN D.P.V. De, SIM D., et al. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Eur J Hear. Fail. 2017;19(12):638–647.
- DELCEA C., BUZEA C.A., VIJAN A., DRAGHICI A., STOICHITOIU L.E., DAN G. Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients. Scand. Cardiovasc. J. 2021;55(4):227–236.
- NAGARAJAN V., HERNANDEZ A. V, TANG W.H.W. Prognostic value of cardiac troponin in chronic stable heart failure : a systematic review. Heart. 2012;98(24):1778–1786.
- OMLAND T., RØSJØ H., GIANNITSIS E., AGEWALL S. Troponins in heart failure. Clin. Chim. Acta. 2014;
- APPLE F.S., WU A.H.B., SANDOVAL Y., SEXTER A., LOVE S.A., MYERS G., et al. Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample Bank. Clin. Chem. 2020;66(3):1–11.
- WESTERMAN S., WENGER N.K. Women and heart disease, the underrecognized burden : sex differences, biases, and unmet clinical and research challenges. Clin. Sci. 2016;551–563.
- SALTON C.J., CHUANG M.L., DONNELL C.J.O., KUPKA M.J., LARSON M.G., KISSINGER K. V, et al. Gender Differences and Normal Left Ventricular Anatomy in an Adult Population Free of Hypertension A Cardiovascular Magnetic Resonance Study of the Framingham Heart Study Offspring Cohort. J. Am. Coll. Cardiol. 2002;39(6):1055–1060.
- SUTHAHAR N., LAU E., BLAHA M., PANIAGUA S., LARSON M., PSATY B., et al. Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure. J Am Coll Cardiol. 2020;76(12).
- BEALE A.L., MEYER P., MARWICK T.H., KAYE D.M. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation. 2018;138:198–205.
- KAUR G., LAU E. Sex differences in heart failure with preserved ejection fraction : From traditional risk factors to sex-specific risk factors. Women’s Heal. 2022;18.
- MAY T., GUPTA A., AHMED R. Sex Differences in Heart Failure With Preserved Ejection Fraction. Cardiol. Rev. 2025;XXX(00).
- OBOKATA M., REDDY Y., MELENOVSKY V., KANE G., OLSON T., JAROLIM P., et al. Myocardial Injury and Cardiac Reserve in Patients with Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2018;72(1):29–40.
- TSUTAMOTO T., KAWAHARA C., YAMAJI M., NISHIYAMA K., FUJII M., YAMAMOTO T., et al. Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Eur. J. Heart Fail. 2009;11(7):653–658.
- PANDEY A., GOLWALA H., SHENG S., DEVORE A.D., HERNANDEZ A.F., BHATT D.L., et al. Factors associated with and prognostic implications of cardiac troponin elevation in decompensated heart failure with preserved ejection fraction: Findings from the American Heart Association Get With the Guidelines-Heart Failure program. JAMA Cardiol. 2017;2(2):136–145.
- CEDIEL G., CODINA P., SPITALERI G., DOMINGO M., SANTIAGO-VACAS E., LUPÓN J., et al. Gender-Related Differences in Heart Failure Biomarkers. Front. Cardiovasc. Med. 2021;7(January):1–10.
- MYHRE P., O’MEARA E., CLAGGETT B., DENUS S. DE, JAROLIM P., ANAND I., et al. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction. Circ Hear. Fail. 2018;11(November):1–9.
- THIBODEAU J.T., PHAM D.D., KELLY S.A., AYERS C.R., GARG S., GRODIN J.L., et al. Subclinical Myocardial Injury and the Phenotype of Clinical Congestion in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction. J. Card. Fail. 2022;28(3):422–430.
- BAKKER M. DE, ANAND A., SHIPLEY M., FUJISAWA T., SHAH A.S. V. Sex Differences in Cardiac Troponin Trajectories. Clin. Chem. 2023;1798–1808.
- RABER I., MCCARTHY C.P., JANUZZI J.L. A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings. J. Am. Coll. Cardiol. 2021;77(10).
- DEFILIPPI C., LEMOS J. DE, CHRISTENSON R., GOTTDIENER J., KOP W., ZHAN M., et al. Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults. JAMA. 2010;304(22):2494–2502.
- MASSON S., ANAND I., FAVERO C., BARLERA S., VAGO T., BERTOCCHI F., et al. Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure: Data From 2 Large Randomized Clinical Trials. Circulation. 2011;125(2):280–288.
- O’CONNOR C.M., FIUZAT M., LOMBARDI C., FUJITA K., JIA G., DAVISON B.A., et al. Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure: Analysis From the PROTECT Pilot Study. Circ. Hear. Fail. 2011;4:724–732.
- FELKER G.M., MENTZ R.J., TEERLINK J.R., VOORS A.A., PANG P.S., PONIKOWSKI P., et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure : insights from the RELAX-AHF study. Eur. J. Heart Fail. 2015;17:262–270.
- ATHER S., HIRA R.S., SHENOY M., FATEMI O., DESWAL A., AGUILAR D., et al. Recurrent low-level Troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int. J. Cardiol. 2013;166(2):394–398.
Language: English
Submitted on: Apr 13, 2026
Published on: Apr 28, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Anamaria Draghici, Caterina Delcea, Gh.-Andrei Dan, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.